Of those countries, 24 said they have a “critically low” supply of HIV medications in a survey conducted by the WHO.
“The findings of this survey are deeply concerning. Countries and their development partners must do all they can to ensure that people who need HIV treatment continue to access it. We cannot let the COVID-19 pandemic undo the hard-won gains in the global response to this disease,” Tedros Adhanom Ghebreyesus, PhD, the WHO’s director-general, told CNBC.
In May, the WHO and the Joint United Nations Program on HIV/AIDS estimated that AID-related deaths could double in sub-Saharan Africa because of disruption of access to medications, CNBC reported.
The main causes of disruption in supply of HIV drugs were the closure of land and air transportation, failure of suppliers to deliver medication and limited access to health services.
More than 25 million people took HIV drugs in 2019, according to CNBC.
Read the full article here.
More articles on pharmacy:
Novartis to pay $678M to settle kickback lawsuit
Drug lobby sues Minnesota over insulin-pricing law
Independent Idaho pharmacy joins Kootenai Health
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
